Skip to Content

A317 (Fenofibrate (Micronized) 67 mg)

Pill with imprint A317 is Yellow, Capsule-shape and has been identified as Fenofibrate (Micronized) 67 mg. It is supplied by Alembic Pharmaceuticals Inc..

Fenofibrate is used in the treatment of hypertriglyceridemia; hyperlipoproteinemia type iib, elevated ldl vldl; hyperlipoproteinemia type iia, elevated ldl; hyperlipoproteinemia; hyperlipoproteinemia type v, elevated chylomicrons vldl and belongs to the drug class fibric acid derivatives. Risk cannot be ruled out during pregnancy. Fenofibrate 67 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for A317

Fenofibrate (Micronized)

Imprint
A317
Strength
67 mg
Color
Yellow
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Fibric acid derivatives
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Alembic Pharmaceuticals Inc.
National Drug Code (NDC)
62332-0084

Get help with Imprint Code FAQs.

Related Images for "A317"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.